Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans

Acta Neuropathologica Communications
Petronela WeisováMichal Novak

Abstract

Pathologically altered tau protein is a common denominator of neurodegenerative disorders including Alzheimer's disease (AD) and other tauopathies. Therefore, promising immunotherapeutic approaches target and eliminate extracellular pathogenic tau species, which are thought to be responsible for seeding and propagation of tau pathology. Tau isoforms in misfolded states can propagate disease pathology in a template-dependent manner, proposed to be mediated by the release and internalization of extracellular tau. Monoclonal antibody DC8E8, binding four highly homologous and independent epitopes in microtubule-binding domain (MTBD) of diseased tau, inhibits tau-tau interaction, discriminates between healthy and pathologically truncated tau and reduces tau pathology in animal model in vivo. Here, we show that DC8E8 antibody acts via extracellular mechanism and does not influence viability and physiological functions of neurons. Importantly, in vitro functional assays showed that DC8E8 recognises pathogenic tau proteins of different size and origin, and potently blocks their entry into neurons. Next, we examined the mechanisms by which mouse antibody DC8E8 and its humanized version AX004 effectively block the neuronal internalizatio...Continue Reading

References

Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S G Greenberg, P Davies
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C M WischikR A Crowther
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C M WischikA Klug
May 1, 1995·Neurobiology of Aging·H Braak, E Braak
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·C M WischikC R Harrington
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·M von BergenE Mandelkow
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·John BerrimanR Anthony Crowther
Jun 16, 2004·FEBS Letters·Rostislav SkrabanaMichal Novak
Jul 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Martin Margittai, Ralf Langen
Apr 28, 2005·The Journal of Biological Chemistry·Marco D MukraschMarkus Zweckstetter
May 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·Y P WangE-M Mandelkow
Mar 14, 2009·The Journal of Biological Chemistry·Bess FrostMarc I Diamond
Jan 5, 2011·Neurobiology of Aging·Peter FilipcikMichal Novak
Sep 16, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kaoru YamadaDavid M Holtzman
Feb 9, 2012·PloS One·Li LiuKaren Duff
Mar 1, 2012·Neuron·Alix de CalignonBradley T Hyman
Mar 31, 2012·The Journal of Biological Chemistry·Najla KfouryMarc I Diamond
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Eva-Maria Mandelkow, Eckhard Mandelkow
Jul 13, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Oskar AdolfssonRyan J Watts
Jul 24, 2012·Biochemical Society Transactions·Norbert ZilkaMichal Novák
Sep 25, 2012·Journal of the American Chemical Society·Shana Elbaum-Garfinkle, Elizabeth Rhoades
Oct 30, 2012·The Journal of Biological Chemistry·Celeste M KarchAlison M Goate
Jan 18, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michiyo IbaVirginia M-Y Lee
Jul 31, 2013·Proceedings of the National Academy of Sciences of the United States of America·Brandon B HolmesMarc I Diamond
Aug 21, 2013·Journal of Alzheimer's Disease : JAD·Lenka LevarskaMichal Novak
Oct 12, 2013·PloS One·Jere E MeredithCharles F Albright
Jan 8, 2014·Alzheimer's Research & Therapy·Todd E Golde
Jan 28, 2014·Biochemical Pharmacology·Miguel Medina, Jesús Avila
Feb 8, 2014·Nature Medicine·Jing L Guo, Virginia M Y Lee
Feb 19, 2014·The Journal of Experimental Medicine·Kaoru YamadaDavid M Holtzman
May 27, 2014·The Journal of Biological Chemistry·Brandon B Holmes, Marc I Diamond
Sep 28, 2014·Proceedings of the National Academy of Sciences of the United States of America·Brandon B HolmesMarc I Diamond
Nov 18, 2014·Neuropathology and Applied Neurobiology·F ClavagueraM Tolnay
Nov 20, 2014·The Journal of Biological Chemistry·Benjamin FalconSuchira Bose

❮ Previous
Next ❯

Citations

Jun 11, 2020·Current Opinion in Neurology·Pavan A Vaswani, Abby L Olsen
May 31, 2020·Acta Neuropathologica Communications·Monika ZilkovaJeroen J M Hoozemans
Jul 14, 2020·Current Opinion in Neurology·Pavan A Vaswani, Abby L Olsen
Apr 30, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Somin KwonEliezer Masliah
Nov 13, 2020·EMBO Molecular Medicine·Patricia ChastagnerChiara Zurzolo
Dec 8, 2020·Brain : a Journal of Neurology·Kanta HorieRandall J Bateman
Nov 5, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Ram Reddy ChandupatlaSenthilvelrajan Kaniyappan
Feb 12, 2021·Ageing Research Reviews·Jianfeng ZhaoXiao-Qing Tang

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
ELISA
size-exclusion chromatography
electrophoresis
dynamic light scattering
immunoprecipitation
Assay
flow cytometry
biosensor
confocal microscopy

Software Mentioned

Prism
Dynamics
OMNIC

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.